pubmed-article:19671842 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:19671842 | lifeskim:mentions | umls-concept:C0006142 | lld:lifeskim |
pubmed-article:19671842 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
pubmed-article:19671842 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
pubmed-article:19671842 | pubmed:issue | 16 | lld:pubmed |
pubmed-article:19671842 | pubmed:dateCreated | 2009-8-14 | lld:pubmed |
pubmed-article:19671842 | pubmed:abstractText | To investigate the clinical relevance of the recently characterized human oncoprotein cancerous inhibitor of protein phosphatase 2A (CIP2A) in human breast cancer. | lld:pubmed |
pubmed-article:19671842 | pubmed:language | eng | lld:pubmed |
pubmed-article:19671842 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19671842 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:19671842 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19671842 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19671842 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19671842 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19671842 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:19671842 | pubmed:month | Aug | lld:pubmed |
pubmed-article:19671842 | pubmed:issn | 1078-0432 | lld:pubmed |
pubmed-article:19671842 | pubmed:author | pubmed-author:IsolaJormaJ | lld:pubmed |
pubmed-article:19671842 | pubmed:author | pubmed-author:IvaskaJohanna... | lld:pubmed |
pubmed-article:19671842 | pubmed:author | pubmed-author:KallioniemiOl... | lld:pubmed |
pubmed-article:19671842 | pubmed:author | pubmed-author:WestermarckJu... | lld:pubmed |
pubmed-article:19671842 | pubmed:author | pubmed-author:JonkersJosJ | lld:pubmed |
pubmed-article:19671842 | pubmed:author | pubmed-author:DarbonJean-Ma... | lld:pubmed |
pubmed-article:19671842 | pubmed:author | pubmed-author:EdgrenHenrikH | lld:pubmed |
pubmed-article:19671842 | pubmed:author | pubmed-author:LiuXiaolingX | lld:pubmed |
pubmed-article:19671842 | pubmed:author | pubmed-author:CômeChristoph... | lld:pubmed |
pubmed-article:19671842 | pubmed:author | pubmed-author:MattilaElinaE | lld:pubmed |
pubmed-article:19671842 | pubmed:author | pubmed-author:ThézenasSimon... | lld:pubmed |
pubmed-article:19671842 | pubmed:author | pubmed-author:ChanrionMaïaM | lld:pubmed |
pubmed-article:19671842 | pubmed:author | pubmed-author:LaineAnniA | lld:pubmed |
pubmed-article:19671842 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:19671842 | pubmed:day | 15 | lld:pubmed |
pubmed-article:19671842 | pubmed:volume | 15 | lld:pubmed |
pubmed-article:19671842 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:19671842 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:19671842 | pubmed:pagination | 5092-100 | lld:pubmed |
pubmed-article:19671842 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
pubmed-article:19671842 | pubmed:meshHeading | pubmed-meshheading:19671842... | lld:pubmed |
pubmed-article:19671842 | pubmed:meshHeading | pubmed-meshheading:19671842... | lld:pubmed |
pubmed-article:19671842 | pubmed:meshHeading | pubmed-meshheading:19671842... | lld:pubmed |
pubmed-article:19671842 | pubmed:meshHeading | pubmed-meshheading:19671842... | lld:pubmed |
pubmed-article:19671842 | pubmed:meshHeading | pubmed-meshheading:19671842... | lld:pubmed |
pubmed-article:19671842 | pubmed:meshHeading | pubmed-meshheading:19671842... | lld:pubmed |
pubmed-article:19671842 | pubmed:meshHeading | pubmed-meshheading:19671842... | lld:pubmed |
pubmed-article:19671842 | pubmed:meshHeading | pubmed-meshheading:19671842... | lld:pubmed |
pubmed-article:19671842 | pubmed:meshHeading | pubmed-meshheading:19671842... | lld:pubmed |
pubmed-article:19671842 | pubmed:meshHeading | pubmed-meshheading:19671842... | lld:pubmed |
pubmed-article:19671842 | pubmed:meshHeading | pubmed-meshheading:19671842... | lld:pubmed |
pubmed-article:19671842 | pubmed:meshHeading | pubmed-meshheading:19671842... | lld:pubmed |
pubmed-article:19671842 | pubmed:meshHeading | pubmed-meshheading:19671842... | lld:pubmed |
pubmed-article:19671842 | pubmed:meshHeading | pubmed-meshheading:19671842... | lld:pubmed |
pubmed-article:19671842 | pubmed:meshHeading | pubmed-meshheading:19671842... | lld:pubmed |
pubmed-article:19671842 | pubmed:meshHeading | pubmed-meshheading:19671842... | lld:pubmed |
pubmed-article:19671842 | pubmed:meshHeading | pubmed-meshheading:19671842... | lld:pubmed |
pubmed-article:19671842 | pubmed:meshHeading | pubmed-meshheading:19671842... | lld:pubmed |
pubmed-article:19671842 | pubmed:meshHeading | pubmed-meshheading:19671842... | lld:pubmed |
pubmed-article:19671842 | pubmed:meshHeading | pubmed-meshheading:19671842... | lld:pubmed |
pubmed-article:19671842 | pubmed:year | 2009 | lld:pubmed |
pubmed-article:19671842 | pubmed:articleTitle | CIP2A is associated with human breast cancer aggressivity. | lld:pubmed |
pubmed-article:19671842 | pubmed:affiliation | Centre for Biotechnology, University of Turku, Turku, Finland. | lld:pubmed |
pubmed-article:19671842 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:19671842 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:19671842 | pubmed:publicationType | Validation Studies | lld:pubmed |
entrez-gene:57650 | entrezgene:pubmed | pubmed-article:19671842 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:19671842 | lld:entrezgene |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19671842 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19671842 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19671842 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19671842 | lld:pubmed |